These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 794724)

  • 1. Comments and findings from a naltrexone double blind study.
    Keegan J; Lavenduski C; Schooff K
    NIDA Res Monogr; 1976 Sep; (9):74-6. PubMed ID: 794724
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experiences with naltrexone in 370 detoxified addicts.
    Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
    NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 6. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 7. Naltrexone treatment of opiate-dependent persons.
    Hollister LE; Schwin RL; Kasper P
    Drug Alcohol Depend; 1977 May; 2(3):203-9. PubMed ID: 880876
    [No Abstract]   [Full Text] [Related]  

  • 8. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of naltrexone use--its efficacy, safety and potential.
    Landsberg R; Taintor Z; Plumb M; Amico L; Wicks N
    NIDA Res Monogr; 1976 Sep; (9):106-13. PubMed ID: 1004529
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of naltrexone treatment.
    O'Brien CP; Greenstein R; Woody GE
    NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of narcotic antagonists (naltrexone) in an addiction treatment program.
    Lewis D; Hersch R; Black R; Mayer J
    NIDA Res Monogr; 1976 Sep; (9):99-105. PubMed ID: 794728
    [No Abstract]   [Full Text] [Related]  

  • 15. Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies.
    Bradford A; Hurley F; Golondzowski O; Dorrier C
    NIDA Res Monogr; 1976 Sep; (9):163-71. PubMed ID: 794717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with naltrexone in a behavioral research study: an interim report.
    Greenstein R; O'Brien C; Mintz J; Woody G; Hanna N
    NIDA Res Monogr; 1976 Sep; (9):141-9. PubMed ID: 794715
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of naltrexone in the treatment of schizophrenia.
    Gitlin MJ; Gerner RH; Rosenblatt M
    Psychopharmacology (Berl); 1981; 74(1):51-3. PubMed ID: 6791204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the National Academy of Sciences study of naltrexone.
    Kaim SC
    NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 20. On the role of chemotherapy in the treatment of heroin addiction.
    Goldstein A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):279-88. PubMed ID: 1227291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.